Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database

Overview of attention for article published in Frontiers in Pharmacology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 21,320 followers.

RT @DrRaulCordoba: #Hematology | Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the ⁦@US_FDA…

28 Nov 2022

Reply Repost Favourite

#Hematology | Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the ⁦@US_FDA⁩ Adverse Event Reporting System (FAERS) database #lymsm #leusm #CLLsm https://t.co/vgF530jQQv

28 Nov 2022

Reply Repost Favourite

Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database #lymphoma #lymsm https://t.co/yP8lXH8Ddf

28 Nov 2022

Reply Repost Favourite

New Research: Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database https://t.co/khM2BpkijC #pharmacology

11 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.